Skip to main content

Table 2 The overall characteristics of PCOS patients and controls

From: Association between ACEgene I/D polymorphisms and hyperandrogenism in women with Polycystic Ovary Syndrome (PCOS) and controls

_

N

Age (years)

AAM (years)

BMI (kg/m2)

FSHIU/L

LHIU/L

LH/FSH

T (nMol/L)

E2 (pMol/L)

PCOS

346

26.49 ± 4.0*

14.57 ± 1.62

22.80 ± 3.79*

8.14 ± 5.91*

(N = 325)

20.39 ± 20.3*

(N = 325)

2.63 ± 1.33*

(N = 325)

4.04 ± 4.12*

(N = 325)

226.92 ± 117.04*

(N = 325)

Control

236

31.64 ± 4.35

14.75 ± 2.66

21.32 ± 2.32

6.97 ± 2.16

(N = 219)

4.55 ± 2.16

(N = 219)

0.67 ± 0.33

(N = 219)

1.6 ± 3.82

(N = 219)

171.64 ± 140.68

(N = 219)

  1. Note: *P < 0.05 vs control. We failed to assay the hormone levels in several women with PCOS and controls.